Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane

British Journal of Pharmacology
F FabiP del Basso

Abstract

1. We investigated the potentiating effect of low concentrations of neuropeptide Y (NPY) on the vasoconstriction induced by transmural nerve stimulation (TNS) and noradrenaline (NA) in human saphenous veins. The effects of (i) endothelium removal; (ii) the addition of the NO pathway precursor L-arginine; (iii) the ET(A)/ET(B) endothelin receptor antagonist Ro 47-0203; (iv) the cyclo-oxygenase inhibitor, indomethacin; (v) the selective thromboxane A2 (TxA2) receptor antagonists Bay u3405 and ifetroban, and (vi) the TxA2 synthase inhibitor, UK 38485, were studied in order to gain information about the mechanisms of NPY-induced potentiation. 2. Contractile response curves for TNS (0.5-8 Hz) and for exogenously administered NA (0.1-3 microM) were obtained in superfused saphenous vein rings. The contractions induced by both TNS and NA at all tested frequencies and concentrations, respectively, were significantly potentiated by 50 nM NPY in endothelium intact veins. Conversely, in endothelium-denuded vessel rings the contractile-response curves to TNS and NA overlapped both in the absence and presence of NPY, thus suggesting that a release of vasoactive substances from endothelial cells could account for the noradrenergic NPY-induced...Continue Reading

References

Jan 14, 1992·European Journal of Pharmacology·D L SmallD W Cheung
Jun 1, 1992·British Heart Journal·T N LuuM H Yacoub
Nov 1, 1991·British Journal of Pharmacology·M G McKenniffP J Gardiner
Feb 6, 1990·European Journal of Pharmacology·V L SavilleG Burnstock
Oct 1, 1988·British Journal of Pharmacology·R Andriantsitohaina, J C Stoclet
Sep 1, 1989·European Journal of Pharmacology·D BudaiS P Duckles
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A InoueT Masaki
Jan 1, 1988·Pharmacology & Therapeutics·E K Potter
Jun 26, 1987·European Journal of Pharmacology·R N Daly, J P Hieble
May 1, 1988·Clinical and Experimental Pharmacology & Physiology·H K Wong-Dusting, M J Rand
Oct 1, 1984·British Journal of Pharmacology·L EdvinssonC Wahlestedt
Jan 1, 1994·Life Sciences·K LiJ L Rouleau
Jul 1, 1993·The Annals of Thoracic Surgery·P J LinM J Hsieh
Nov 1, 1995·Journal of Cardiovascular Pharmacology·T C WestfallM Curfman-Falvey

❮ Previous
Next ❯

Citations

Nov 6, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Antonio P SilvaEric Grouzmann
Dec 29, 2000·Fundamental & Clinical Pharmacology·S SimonetT Verbeuren
Sep 29, 2009·Domestic Animal Endocrinology·C S KeatorJ A McCracken
Apr 27, 2005·Biology of the Cell·Antonio P SilvaEric Grouzmann
May 12, 2011·British Journal of Pharmacology·Matthias BartonMatthias R Meyer
Jul 18, 2006·European Journal of Pharmacology·Tatsuru TsurumakiHiroshi Higuchi
Jan 11, 2005·Rheumatic Diseases Clinics of North America·Sergio GeneriniMarco Matucci-Cerinic
Jan 10, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·J YouR M Bryan
Sep 7, 2007·American Journal of Physiology. Renal Physiology·Ean Y CallananZofia Zukowska
May 31, 2018·Journal of Neuroengineering and Rehabilitation·Mark BrintonDaniel Palanker
Aug 3, 2001·Cardiovascular Drug Reviews·L RosenfeldC T Stier
May 27, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Johannes HartlReiner Wiest
Apr 9, 2015·Journal of Cardiovascular Pharmacology·Olayemi O AdeoyeWilliam J Pearce
Mar 13, 2021·Frontiers in Cardiovascular Medicine·Yan-Li ZhengHui-Li Lin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.